Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 15, 2002

View Archived Issues

New licensing agreement signed by JT for JTE-522

Systemic antitumor response follows s.c. or intrahepatic suicide cell-based vaccination

New antedrugs with therapeutic potential in psoriasis

Potential therapeutic agent for Chagas' disease enters development

Natural plant pigment exerts chemopreventive effects in mouse colon cancer model

Wyeth-Ayerst engineers new transgenic rat model for ALS research

Vernalis and Roche collaborate on diabetes drug development

Morphine-sparing analgesic effects demonstrated for valdecoxib in knee replacement surgery trial

Shareholder approval for Millennium and Cor Therapeutics merger

aaiPharma licenses rights to Tanatril in U.S.

FDA approves BioStratum's IND for antiangiogenesis agent

CCL's Aspirair technology incorporated into Vectura business

AVI BioPharma licenses calicivirus patent

Patient enrollment begins for ALVAC-CEA/B7.1 study in colorectal cancer

Discovery Therapeutics changes name to Aderis

TAK-457 may be more effective than amphotericin B as Rx for invasive pulmonary aspergillosis

Preparation and use of new glucagon receptor antagonists/inverse agonists patented by Novo Nordisk

Pfizer synthesizes JAK3 inhibitors potentially useful as immunosuppressants

Recent patent discloses NMDA NR2B antagonists designed at Merck

Novel factor Xa inhibitors for treatment of thromboembolic disorders

Eisai seeks FDA clearance for new indication of Aciphex/Pariet

Tripeptide prodrugs of therapeutic agents with improved toxicity profile prepared at Corixa

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...